Results 131 to 140 of about 1,717 (156)
Some of the next articles are maybe not open access.
Dalbavancin, tedizolid phosphate, oritavancin diphosphate, and vedolizumab
Journal of the American Pharmacists Association, 2014Antibacterial agents Skin and skin structure infections are most often caused by Grampositive bacteria such as streptococci and staphylococci. The number of these infections that are caused by methicillin-resistant Staphylococcus aureus (MRSA) has rapidly increased in recent years in both the community and hospital settings.
Daniel A, Hussar, Angelique, Nguyen
openaire +2 more sources
Enfeksiyon Görüntüleme ve Tedavisi için 177Lutesyum-Tedizolid
Fabad Journal of Pharmaceutical Sciences, 2022Enfeksiyon hastalıkları hala dünyada temel sağlık problemlerinden birini oluşturmaktadır. Enfeksiyonun erken aşamalarda teşhisi ve kanser veya inflamasyon gibi diğer patolojilerden ayrımı, enfeksiyonu akut aşamalarda tedavi etmede kritik rol oynamaktadır.
Merve KARPUZ +3 more
openaire +1 more source
Monitoring Salivary Concentrations of Tedizolid and Linezolid Using Rats
European Journal of Drug Metabolism and Pharmacokinetics, 2023Therapeutic drug monitoring (TDM) is an effective tool for the management of patients who are administered linezolid. The use of saliva for TDM has potential advantages over the use of plasma; however, only a few reports have compared drug concentrations in the saliva and plasma. Moreover, there are no reports on the salivary concentration of tedizolid,
Yuki Inoue +5 more
openaire +2 more sources
Tedizolid (TR-701): a new oxazolidinone with enhanced potency
Expert Opinion on Investigational Drugs, 2012Tedizolid phosphate (TR-701) is a new oxazolidinone prodrug that is transformed in the serum into the active drug tedizolid (TR-700). Tedizolid acts by inhibiting protein synthesis and has broad activity against Gram-positive pathogens, including strains that are resistant to linezolid.This review summarizes the currently available data on this new ...
Zeina A, Kanafani, G Ralph, Corey
openaire +2 more sources
Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014Antimicrobial resistance among gram‐positive organisms such as methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant enterococci (VRE) continues to limit therapeutic options. The oxazolidinones are a synthetic class of agents now commonly relied on for the treatment of serious MRSA and VRE infections.
Jeffrey M, Rybak +2 more
openaire +2 more sources
Tedizolid for osteoarticular infections: Evaluation of the published evidence
European Journal of PharmacologyTedizolid phosphate, an oxazolidinone antibiotic, has been approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). However, its off-label use has been reported in various infections, including osteoarticular infections.A systematic review of data from PubMed, Scopus, and Web of Science was conducted to evaluate the ...
Veatriki Athanasiou +4 more
openaire +2 more sources